Xencor develops engineered antibody drugs for cancer and autoimmune diseases and partners with other drugmakers on its technology. XNCR reports earnings on Wed, Nov 4, 2026. Analyst consensus is Strong Buy, based on the latest ratings from 9 firms (7 buy, 2 hold, 0 sell).
Earnings
Earnings calendar →Analyst Ratings & Price Targets
Analyst Ratings →| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Oct 27 | Truist Securities | Target raised | Buy | |
| Oct 27 | RBC Capital | Target raised | Buy | |
| Oct 27 | Wells Fargo | Maintained | Buy | |
| Oct 27 | Wedbush | Target raised | Buy | |
| Sep 28 | Truist Securities | Target raised | Buy |
Whale Options Flow
90DNo whale options trades in XNCR in the last 90 days.
AI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether XNCR is in one of them and how their past XNCR trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered XNCR in an article yet. Here's the latest on the wider market.
XNCR Congress Trades
All congress trades →
| Person | Type | Amount | Traded | Filed | Delay |
|---|---|---|---|---|---|
| Donald J TrumpExecutive branch | Sell | $1K – $15K | Jul 29, 2026 | Sep 22, 2026 | 55 d |
Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.
About Xencor
Xencor is a biopharmaceutical company based in Pasadena, California, that designs engineered antibody drugs. Its work focuses on cancer and autoimmune diseases, and it uses its own protein engineering technology to build antibody drug candidates, several of which are in clinical trials. The company also licenses its antibody design technology to pharmaceutical and biotechnology partners, who may develop or market the resulting medicines.
- Headquarters
- Pasadena, CA